Related Experiment Video
Updated: Oct 4, 2025
06:16
Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models
Published on: March 16, 2022
3.2K
Abstract:
Tebentafusp, the first drug shown to extend overall survival in people with uveal melanoma, was greenlighted by the FDA in late January to treat patients with inoperable or metastatic forms of the aggressive eye cancer. The drug is also the first T-cell receptor therapy to reach the market.
Insights
Tebentafusp is a new FDA-approved drug for advanced uveal melanoma. This T-cell receptor therapy is the first to extend overall survival in patients with this aggressive eye cancer.
Area of Science:
- Oncology
- Immunotherapy
Background:
- Uveal melanoma is an aggressive form of eye cancer.
- Limited treatment options exist for inoperable or metastatic uveal melanoma.
- Tebentafusp represents a novel therapeutic approach.
Purpose of the Study:
- To evaluate the efficacy of Tebentafusp in patients with unresectable or metastatic uveal melanoma.
- To assess the impact of Tebentafusp on overall survival.
Main Methods:
- Tebentafusp is a bispecific protein that targets tumor cells and immune cells.
- It is a T-cell receptor therapy, a type of immunotherapy.
- Clinical trials were conducted to assess its safety and efficacy.
Main Results:
- Tebentafusp demonstrated an extension in overall survival for patients with uveal melanoma.
- It is the first drug to show this survival benefit in clinical trials.
- The FDA approved Tebentafusp for treating this condition.
Conclusions:
- Tebentafusp is a groundbreaking treatment for uveal melanoma.
- It offers a new hope for patients with advanced stages of the disease.
- This marks a significant advancement in the treatment of eye cancers.
Related Concept Videos
01:26FDA Approved Drugs: Changes to Approved Drugs
6
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
6
01:28Angle Closure Glaucoma: Treatment
874
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
874
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
01:02Prescription, Nonprescription and Orphan Drugs
883
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
883
01:27Open Angle Glaucoma: Treatment
741
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
741
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K